A few previous works of the authors derived and discussed the space-time mathematical description, the PhasTraM model, for oncogenic hyperplasia regarded as a genotoxically activated homeorhetic dysfunction. The model is based on the fluid-tosolid-and-back transitions and nonlinear reaction-diffusion equation relevant to a series of the key biomedical facts and distinguishing features of living systems. The first computer-simulation results have also been reported. The present work generalizes the PhasTraM model for the effect of radiation therapies (RTs), both external and internal. The resulting model also includes the autocrine mechanism promoting oncogenic hyperplasia and the suppression of this process by certain drugs. The autocrine signalling is implemented by the transforming-growth-factor-α (TGF-α) molecules released by the cells and bound to the epidermal-growth-factor receptors (EGFRs) at the cell surface. The suppression can be carried out by a drug deactivating the mentioned molecules. The work also presents and discusses examples of the computer-simulation results for four different settings of the applied RT. A few directions for future research as well as prospective applications of the model and developed software are also discussed.
Introduction
The ability of a living system to maintain a static equilibrium independently (in sufficiently large time intervals) of exogenous (external, coming from outside a system) signals bears name homeostasis [1] . An example of homeostasis is the ability of the body to maintain an internal temperature at a constant level, no matter what is the external temperature (within a certain range). Homeorhesis [2] is the time-dependent generalization of homeostasis. Homeorhesis concerns the dynamic rather than static equilibrium of the system, in which continuous changes of the steady state occurs.
A tumour is an abnormal new mass of tissue that results from uncontrolled division of the cells. Tumours perform no useful body function. They may be either benign (not cancerous) or malignant (cancerous). Oncogeny, i.e. formation of a tumour, progresses in a sequence of steps: hyperplasia, dysplasia, growth in situ, angiogenesis, and invasion. As it is well known in biomedicine, oncogenic hyperplasia is the first and therefore inevitable stage in development of any (solid) tumour. Oncogenic hyperplasia is also implicated in many other proliferative diseases: vascular; gastrointestinal; endocrine; proliferative dermatoses (infantile eczema and lichenification); megakaryocytic or platelet hyperplasia; hyperplasia of cardiac muscle; hyperplastic lesions of the larynx; ductal, prostatic, intimal, endometrial, and lymphoid hyperplasias; and others. Oncogenic hyperplasia is a process that is continuous in space and time where quantitative changes in the cell-population characteristics result in qualitative differences. As it is well known (e.g., [3, 4, 5] ), oncogenic hyperplasia is a genotoxically activated homeorhetic dysfunction.
The minimal mathematical model that takes into account the listed features was developed in [6] (see also [7, 8] ). The purpose of the present work is three-fold:
• incorporation of the effects of radiation therapies (RTs) (both external and internal) into the previous model;
• endowing the above RT-aware model with capabilities allowing for a simultaneous action of RT and drugs;
• illustration of the RT influence upon oncogenic hyperplasia with computer-simulation results.
Sections 2 and 3 emphasize the key biomedical facts and distinguishing features of living systems to be accounted in the modelling. Sections 4 and 6 presents two parts of the description of the RT-aware model. Sections 5 and 7 discuss the modelling parts in Sections 4 and 6, respectively. The computer-simulation results are described and analyzed in Section 8. Section 9 presents the concluding remarks and suggests a few direction for future research.
Biomedical facts to be accounted in the modelling
In order to develop any mathematical model relevant to the hyperplastic tumour formation, a series of biomedical facts should be taken into account. The most important of them are listed below:
• oncogenic hyperplasia is the first stage of any solid tumour development (see Section 1);
• oncogenic hyperplasia is a homeorhetic dysfunction (see Section 1);
• there is no sharp boundary between a tumour and the surrounding population of homeorhetic cells; instead, there is a continuous and complex layer of the cells;
• tumour can be of any shape; it need not be spherical;
• in any spatial domain, the cell population may be at one of the two robust, i.e. asymptotically stable, states: the homeorhesis state that corresponds to a medium-density physical phase of the population and the tumour state that corresponds to a highdensity (closest-packed, solid-like) physical phase of the population; which phase is the case in a spatial domain depends on the spatio-temporal distribution of the critical, unstable state;
• oncogenic cells can infinitely proliferate in vitro even without a growth-supporting serum, not to mention the nutrient substances necessary for normal cells and the extracellular matrix (ECM) (see Encyclopedia Britannica Online: "Endocrine system: Transforming growth factors");
• as is well known in biomedicine (e.g., [9, 10] ), the above proliferation is explained by the autocrine mechanism when, for instance, the transforming growth factor α (TGF-α) molecules bind their corresponding receptors, epidermal growth factor receptors (EGFRs);
None of the above facts can be neglected in the development of meaningful models. They underlie the present model described in the Section 4. The next section discusses the distinguishing features of living systems.
Distinguishing features of living systems
The main distinguishing features of the dynamical behaviour of a living system are well known in biology since long ago [2, Chapter 2], [11] (see also [12] for a recent discussion). They are formulated in terms of ordinary differential equations (in Euclidean or function Banach spaces) for the first time in [13, Appendix] . The present section summarizes the latter consideration and indicates the corresponding reaction-diffusion equation (RDE) applicable to oncogenic hyperplasia.
The aforementioned features are the following.
(i) A living system includes at least one living cell.
(ii) A living system is an open system, i.e. can exchange energy and matter (e.g., cells, molecules, atoms) with the surrounding. Since the system is open, it includes at least one, generally time-varying exogenous (i.e. environmentally driven) signal.
(iii) A living system develops along the trajectory (in the space of the system states) that is completely determined by the internal properties of the system and its environment, i.e. the related exogenous signals. [14] .
One usually associates dynamics of any living system with the purposeful behaviour, however, without suggesting the corresponding "mechanism" or specifying the terms. Resolving the latter problem is substantially contributed by Waddington's theory of homeorhesis. Indeed, it follows from feature (v) that the homeorhetic "mechanism" indicates the creode trajectory (which is independent on the actual exogenous signal) as the "purpose" of a living system. This purpose is not invariable: its evolution is described with the creode dynamics.
Remark 3.1 Exogenous signals are parameters of the environment of a living system but are not parts of the system. They vary in time smoothly and are independent of the moments t B and t D (t B < t D ) of the birth and death of the system.
We denote an exogenous signal with s(t) and regard it as a vector in the k-dimensional Euclidean space, i.e. s(t, x) ∈ R 3 where x = (x 1 , x 2 , x 3 ) T ∈ R k and k ≥ 1. In view of Remark 3.1, s(·, x) ∈ B k where B k is the set of the functions which have values in R k , and are defined, sufficiently smooth, and uniformly bounded in the entire time axis R. We also denote the "most favored" exogenous signal (or formative drive) mentioned in feature (iv) with s c (t, x). It need not coincide with actual exogenous signal s(t, x) and hence is, generally speaking, hypothetical. As explained in [13, the text below (A.11)], it is "designed" by the living system itself and is related to what is in biology known as "the wisdom of the body" (cf., [14] ).
Waddington (see [2, p. 22] ) suggested to regard the state-space of a living system as Euclidean space, say, R n (n ≥ 1) and to describe the system with an ODE of a fairly general form in R n . The coordinates in the state space can include, for instance, concentrations (or volumetric number densities) of cells or molecules [2, Chapter 2 and Appendix].
Let m be the so-called scaled concentration of the cells in a population (e.g., [7, 8, 6 ], see also (2) below). Note that m > 0 because of feature (i). Let also m c be the creode value of m. The simplest space-time model for morphogeny is an RDE (e.g., see [6, Section 10] for a recent discussion). Assume that concentration m is described with an RDE where the diffusion coefficient D of a cell is space-time-independent. Then it follows from the results of [13, Appendix] that the RDE can be of the following form
where column ∇ is the Hamilton differential expression in the spatial coordinates x 1 , x 2 , and x 3 , i.e. ∇ = (∂/∂x 1 , ∂/∂x 2 , ∂/∂x 3 ) T , Φ is certain sufficiently smooth function of respective variables, and m c is uniformly bounded for all t ∈ R. Equation (1) can be regarded as the equation not only for the scaled cell concentration m but also for the cell concentration n (see (2) below). The corresponding NRDE for n (e.g. [7, Appendix B] ) is a description of homeorhesis in the particular case when the sensitivity of n with respect to the exogenous signals has already decayed to zero (cf., [13, (A.6 ) and Theorem A.1]), and therefore the term which represents the above sensitivity is not accounted explicitly. However, its resulting influence upon m is represented with the initial condition (see (10) below).
Note that the creode value m c (t, x) is uniformly bounded for all t [13, Appendix] . Further details on the differential-equation solutions uniformly bounded for all t can be found in [15] . In theory of Markov stochastic processes, invariant (generally, nonstationary) processes (e.g., [16] ) are analogues of the above solutions of determinate differential equations.
The advantage of description (1) is that it does not presume to model creode concentration m c : the latter can be obtained from the corresponding experimental data (e.g., see [17] for examples of these data). Function Φ is derived independently of the creode modelling in [6] within the PhasTraM approach. The PhasTraM form of (1) is discussed in Section 4.
Model description
The PhasTraM model of [6] (see also [7, 8] ) allows for an insight into the cell proliferation. It describes the space-time evolution of the cell concentration n and the cell-population transitions between the two phases noted in Section 2. These phases correspond to the creode concentration n c and the hyperplastic-tumour concentration n T . Between these asymptotically stable values there must be a concentration value which is unstable and, thus, critical. It is denoted with n. The PhasTraM model extends the well-known theory of the first-and second-order non-equilibrium phase transitions due to chemical reactions [18] .
We denote with subscript "×" the values of respective variables corresponding to the case when RT is not applied, i.e. r ≡ 0. In the present work the term "parameter" is only applied to the characteristics which are independent of concentrations of cells or molecules.
The PhasTraM model [6] applies the so-called scaled concentration (see [6, Section 2] )
where Υ is the effective volume of a cell and φ is the volume fraction occupied by bodies of ECM which can be regarded as immobile. Note that φ does not include the fibres that may be located within the effective volume. Parameter Υ is defined as Υ = υ/ζ where υ is the actual volume of the cell and ζ is the ratio of the fraction of the volume occupied by the bodies of the cells to the fraction of the volume unavailable to the cell motion, ζ ∈ (0, 1] (for hard spheres ζ ≈ 0.75). It follows from (2) that
where
The equation describing the space-time evolution of m is the NRDE of work [6] extended with the RT-term r, namely
where m + is explained below (see (21)), D is the diffusion coefficient of a cell, the last term on the right-side is the biochemical-reaction (BCR) term, η × is the lifetime of a cell in the ideal-homeorhesis state m + = ∞ ,
m c is the creode value of m (see Section 3), m + is the critical value of m, r is the rate of cell death caused by RT, r = u + κ n I ,
and c × is determined as follows
In the above formulas, ξ × is the total duration of the S and M cell-cycle stages, θ × is the total duration of the G1 and G2 cell-cycle,
g × is the genotoxicity of a cell, u is a rate of decrease of m due to the external RT, κ is a coefficient related to the internal RT and n I is a concentration of the radioactive substance used in the internal RT.
For the reasons noted in the text below (1), we consider the initial condition for (5), namely lim
where initial scaled concentration m 0 is coupled with initial concentration n 0 by means of (3). Values n 0 (x) are obtained from the related experiments.
As it is shown in Appendix A.1, equation (5) can be presented in the more concise form, namely
Since the form of (11) is the same as that of the NRDE studied in [7, 8, 6] , the analytical results of these works are applicable. They include the following relations:
Appendix A.2 shows how the durations of the cell-cycle stages depend on applied radiation
Another necessary relation
is derived in Appendix A.3. Expression (see Appendix A.4)
generalizes (6) to the case when r need not be identically equal to zero. Inequalities (17) agrees with the corresponding experimental data (e.g., [19, p. 926] ). Inequality
is interpreted as the threshold that prevents the cells from entering the G0 stage of the cell cycle, thereby transferring them into the nonquiescent ones.
Remark 4.1
The present model presumes that cell genotoxicity g × (see (9) )
depends on space and time and, in the course of time, can rapidly change from low to high values (and back) thereby (see (8) , (21) , and (12)) providing the switching m between high and low values. When inequality (23) holds, oncogeny begins. It lasts as long as the inequality is valid. When it is no longer valid, a resulting hyperplastic tumour disintegrates.
The above results enable one to derive expression (see Appendix A.5)
and inequalities (see derivation in Appendix A.6)
The first inequality in (25) is equivalent to
Remark 4.2 Relation (26) is a specific quantitative criterion to design and plan RTs. It can serve as a guidance to optimize the settings for the intensity-modulated RT (IMRT) technique (e.g., [20] ) or to determine the space-time dependence of n I used by an internal RT (see for more details Section 5).
Since the x-domain in (5) is the entire space R 3 , the initial-value problem (11), (10) is the Cauchy one. An analytical-numerical time-slices (TS) method to solve this problem is available (see [6, Appendix C] or [21, 22] ). The key advantages of the TS method are that it is applicable to nonlinear RDEs, equally efficient in simulation of both asymptotically stable solutions (i.e. when m → m c ) and unstable solutions (i.e. when m → ∞), and is sufficiently fast to provide efficient multiple analysis.
Remark 4.3
In the present model, creode concentration m c is assumed to be independent of the RT-related rate r ≥ 0 (see (7) ). This in particular results in inequality (26). In other words, the sufficiently low values of r prescribed by (26) corresponds to the r-independence of m c . Thus, the higher values of r can be the case only if the creode is affected by RT.
However, in view of the meaning of the creode (see Section 3), the creode alteration by RT may cause iatrogenic diseases thereby changing the status of the RT treatment from a therapy to something which is probably opposite to therapy. The iatrogenic effect of RT as well as the related biomedical, ethical, and legal issues are beyond the scope of this work.
Other terms related to the above model (see (11) ) are introduced in Section 6.
Discussion of the model in Section 4
The model of the previous section applies the initial value of the cell scaled concentration m 0 resulting from input parameter n 0 by means of (3). Since the model describes a spatially growing tumour, n 0 must be a function of the space point. The present measurements in vivo do not resolve the cell concentration in space. Nevertheless, it is possible to make approximate characterization of the shape of n 0 on the basis of several point biopsies. In the clinical practise, a widely used procedure for obtaining cytological parameters at a location of interest to physicians is the fine needle aspiration biopsy (FNAB). It is, in contrast to surgical biopsy, safer and less traumatic for the patient. The FNAB procedure is frequently performed in breast, thyroid, lung, upper abdomen, kidney and bone marrow studies. In order to ensure the appropriate accuracy, the stereotactic needle biopsy is performed, a biopsy in which the spot is located three-dimensionally by means of ultrasound, MR or CT imaging.
The model in Section 4 includes relations for certain characteristics of the cells, such as (13) , (19) and (20) , which depend on r. The r-dependences in (19) and (20) qualitatively agree with what is known from the phenomenological description of the RT influence on the cell cycle (e.g., [23] ). The advantage of mathematical modelling is the possibility to predict the cell-related effects not only after application of RT but also at a time when RT is applied.
Inequality (26) gives a consistent and specific recipe for designing the shape of r. The r should, however, be close to the right-hand side of (26) as much as possible. This quantitative description can be used as an additional factor for the planning RT, also in such an advanced method as like IMRT.
6 The TGF-α/EGFR interpretation of the present model
The BCR term in NRDE (11) is a rational function of m. This form can be explained in terms of the interaction of the TGF-α molecules with EGFRs in the following way.
One considers equation system more general then NRDE (11), namely
where p and q are the coefficients to be determined, ν is the TGF-α molecule concentration, D ν is diffusion coefficient of a TGF-α molecule, τ is the lifetime of a TGF-α molecule, a is the autocrinity of a cell and ν T is the value of ν corresponding to n T . The gain term amν T on the right-hand side of (28) describes the production of TGF-α molecules by the cells, and the loss term −amν describes the decrease in TGF-α molecules due to their binding by the cells.
Remark 6.1 Parameter τ can include various effects. For instance, the effect of the TGF-α-molecule-deactivating drug can be accounted in the following expression
where n II is the concentration of the drug, τ 0 is the value of τ at n II = 0, and ω ≥ 0 is the corresponding coefficient. In general, the specific expressions for τ depend on specific problems.
Involving the quasi-stationary approximation in (28), i.e. neglecting all the derivatives in (28), one obtains expression (see the derivation in Appendix B.1)
where g is described with (24) . The coefficients p and q in (27) should be selected in such a way that, after substituting (30) into (27), one arrives with (11) . Incorporation p and q into (27) leads to more detailed expression (see derivation of (B.4) and (B.6) in Appendix B.1 for p and q, respectively)
where ν is the value of ν that corresponds to m. As it is shown in the part of the text in Appendix B.1 on the derivation of the BRC coefficient in (31), quantity ν has the following form
It is possible to derive another expression for g (see Appendix B.1), namely
This relation explains genotoxicity g by means of autocrinity a and the TGF-α-molecule lifetime τ , both are the kinetic parameters. The RT-free version of (33) is
Subsequently, the coupling of a and a × is similar to that of g and g × (see (24) ). (33) and (24) (see also (9)) present an explicit analytical connection between the cell-cycle parameters θ × and ξ × , on the one hand, and kinetic parameters a and τ , on the other hand. This coupling, expressed explicitly, points out the cell-phenomena connection that has not been revealed before.
Remark 6.2 Equations
A furter analysis of the model leads to an expression for ν T which depends on parameter (38) and ν c (see Appendix B.2 for the derivation),
As it is well known from experiments (e.g. [24, Figure 8(B) ]), the dependence of n (see (3)) on ν (see (30)) is linear. Such dependence straightforwardly results in relation
if one assumes that the linearity is the case even if RT is applied. Note that the cell effective volume Υ is never less than the cell volume υ and is equal to the latter at the creode state, i.e. Υ ≥ Υ g=gc = υ .
This and (36) in particular show that
On the basis of (36), one can obtain the following equations (see Appendixes B.3 and B.4 for the derivation of (39) and (40), (41), respectively)
Value n T is derived in Appendix B.4. The present model is discussed in the next section.
Discussion of the model in Section 6
In the present model genotoxicity g is a function of τ and a (see (33)). Nevertheless, when those parameters are unavailable, g can be calculated by means of parameters of the cell-cycle duration (see (24) and (9)). Quantity τ in (33) can easily be obtained from the measurements of the lifetime of TGF-α molecules in the surrounding where the cells are not present. An obtaining autocrinity a in (33) seams to be more complicated. A model for a is to be developed. This model should describe the interaction of TGF-α molecules and their receptors at the cell surface, as well as the production of the molecules by the cells. The molecule-receptor binding may be rather complex. Since φ is the volume fraction occupied by the ECM part located beyond the effective volume of a cell, relation (41) describes the ECM degradation at growing genotoxicity g, the phenomenon is closely associated with oncogenic fibroplasia. The latter may be performed also within the effective cell volume Υ. This means that the present model includes a concise fibroplasia description complementing the autocrine origin of oncogeny. The mentioned coupling is in line with, and further develops, the well-known modelling vision reported in [25] . 
Examples of numerical results
The time-slices (TS) method described previously in [6, Appendix C], [21, 22] Figures 3 and 4) . The cell genotoxicity g × (t, x) is used as an input parameter. (The aftergrowth drop in it may represent the action of, for instance, the immune system.) Other input parameters for all of the examples are quantified as follows: φ = 0.2, υ = 5 × 10 −7 mm 3 , ξ × = 1 day, D = 0.01 mm 2 /day, and n c (t, x) = 10 4 mm −3 . Initial concentration n 0 (x) (see the text below (10) and Section 5) is assumed to be the sum of n c and the "bell"-shaped deviation from n c (see the data in Figure 1-4 (a) at t = 0). The shape of the g × (t, x) surface for the second example is shown in Figure 2(b) . In the other examples, the g × (t, x) surface has the shape presented by Figure 1 Figure 1(a) shows the changes of the cell concentration n(t, x) corresponding to g(t, x) in Figure 1(b) . As one can see, n decreases down to the creode value n c (t, x) during a short time and then, because of the increase in g(t, x), begins to grow, and, in the time limit, tends to the tumour value n T thereby forming a tumour. The tumour value is determined with the equality in Appendix B.4, specifically, n T = 1.6 × 10 6 mm −3 (lg n T ≈ 6.2). The tumour is formed since the cell genotoxicity g(t, x) keeps a sufficiently high value represented with the top of the "ridge" in Figure 1(b) (cf., Remark 4.1) .
In the second example (see Figure 2) , the cell genotoxicity g(t, x) keeps a high value during a short time interval only (see Figure 2(b) ). As a result (see Figure 2(a) ), the cell concentration n does not continue to tend to the value n T (cf., Figure 1(a) ) but, due to the decrease in g(t, x) in the course of time, begins to drop down to the creode value n c , as it should be (see Remark 4.1).
The third and fourth examples examine the influence of RT on the growth dynamics of the cell population. As it is discussed in Section 5, the closer r is to the value of the right-hand side of (26) the more effective RT is. To study a mere manifestation of the RT effect, it is sufficient to use some constant parameter γ, which characterizes the effectiveness of RT (cf. (26)), namely In the present examples, we used γ = 0.93 . Figure 3(a) shows the changes in cell concentration n(t, x) corresponding to g(t, x) (see Figure 3(b) ). The drop of the value of g(t, x) is due to the action of RT. The decrease in g(t, x) results in the decrease in the cell concentration (see Figure 3(a) ). The later return of g(t, x) to its maximum value leads to a continuous growth of n(t, x) resulting in the limit tendency to n T . Figure 3 (c) presents the cross-sections through the n c , n, n, and n T surfaces. The cross-section abscissa corresponds to the maximum-in-x values of n along the t-axis. The change in the profile of n (see dot-dashed line) is due to the action of RT. The "switching" character of n is easily seen in this figure.
The last example (see Figure 4 ) presents a successful application of RT, i.e. the one leading to disintegration of the tumour. Figure 4 (a) shows cell concentration n(t, x) and Figure 4 (b) shows the corresponding g(t, x) function. The longer action of RT, namely for 3 days greater then in previous example, is presented with the longer "gap" in the shape of g(t, x) and is sufficient to suppress the tumour growth. Figure 4 (c) with the cross-sections through the n c , n, n, and n T surfaces illustrates the suppression because n does not intersect n.
The aforementioned examples explicitly demonstrate the main capabilities of the model developed in Sections 4 and 6. The next section summarizes and concludes the work.
Concluding remarks and directions for future research
Summing up the present work, we note the following two groups of the results which correspond to the purpose formulated in Section 1.
The first group of the results is related to the generalization of the oncogenic-hyperplasia model [7, 8, 6, 21] for the effects of both external and internal RTs. The main equations in the resulting model are NRDE (11) and initial condition (10) . Other related quantities are described in Sections 4 and 6. The RT-term r (see (7)) includes the external-and internal-RT terms. Moreover, the explicit analytical expressions are derived for the influence of the RT-term upon the key characteristics of the cell population such as:
• the ideal-homeorhesis lifetime of a cell (see (13) );
• the total duration of the S and M stages of the cell cycle (see (19) );
• the total duration of the G1 and G2 stages of the cell cycle (see (20) );
• the cell genotoxicity (see (24) );
• the critical cell concentration (see (21) and Remark 4.1);
• the cell autocrinity (see (33) • the oncogeny-caused ECM degradation (see (41)).
Moreover, the explicit analytical results include:
• the specific quantitative recipe (26) to design or plan external or internal RTs (see Remark 4.2 for the details; see also Remark 4.3);
• the straightforward connection (by means of the cell genotoxicity g) between the cellcycle parameters (see (9)), on the one hand, and the cell autocrinity (see (33)), on the other hand (see Remark 6.2 for further details).
The list of the input and output parameters of the above, RT-aware generalization are in Tables 1 and 2 , respectively. Each of them has a distinct biomedical meaning. sum of the duration of the S and M cell-cycle stages at r ≡ 0 φ c creode value of volume fraction occupied by the ECM u rate of the decrease in concentration m due to the external radiotherapy κ coefficient related to the internal radiotherapy n I concentration of a radioactive substance used in the internal radiotherapy a × autocrinity of a cell at r ≡ 0 * τ lifetime of a TGF-α molecule when there are no cells ν c concentration of TGF-α molecules which corresponds to n c ω coefficient related to TGF-α blocking drug n II concentration of the drug molecules which bind to the TGF-α molecules preventing the latter from the binding to the cell EGFRs * because of (34) one can apply g× as an input parameter instead of a×; if so, g× can be evaluated from (9) on the basis of the data for ξ× and θ×
The second group of the results of the work is associated with the fact that the developed model includes the action of the drug molecules which deactivate the TGF-α molecules by binding to them. This is presented with the drug-molecule concentration n II and coefficient ω in (29). The latter, together with (24) and (9), explicitly shows how the above deactivation affects the genotoxicity of a cell and the cell-cycle parameters. The TGF-α-deactivating drug can be used in conjunction with RT, thereby improving the effect of the latter.
The developed model and related results draw attention to various directions for future research. We mention a few of them.
• Specification of the RT term r (see (7)) by means of the input physical parameters common to the end users.
• Coupling of the modelling/simulation with the corresponding experimentally available data for the cell-cycle parameters employed in (9).
• Incorporation of the autocrinity model as well as the aforementioned RT-term r (see (7) ) and the TGF-α-deactivating-drug terms into the present software. This presumes application of the related numerical-simulation results to the RT-design/planning recipe (26). In so doing, g can come from either (9) or (33), whereas other parameters are extracted from experiments.
• Validation of the model and calibration of its parameters on the basis of the available in vivo measurements. homeorhetic scaled concentration of cells n T tumour value of n n critical value of n m critical value of m g genotoxicity of a cell c auxiliary parameter which is in a one-to-one correspondence to g ξ sum of the duration of the S and M cell-cycle stages θ sum of the duration of the G1 and G2 cell-cycle stages η homeorhesis lifetime of a cell g × value of g at r ≡ 0 c × value of c at r ≡ 0 θ × value of θ at r ≡ 0 (θ × is output parameter only if both a × and τ are input parameters (see the footnote in Table 1 )) η × value of η at r ≡ 0 ν T value of ν which corresponds to n T Υ effective volume of cells φ volume fraction occupied by the extracellular matrix
• Incorporation of a model of oncogenic fibroplasia (e.g., [25] ) that will provide a combined, hyperplastic-fibroplastic description. (The latter will noticeably generalize the present, quite concise representation (41) for the ECM degradation.)
• Development of the software version that will provide the simulation for two-dimensional spatial domains.
The proposed model, minimal but fairly capable, can be regarded as a specific theoretical, mathematical and computer-simulation tool in tackling complexity in oncology by means of a cohesive multidisciplinary efforts. The main applications of the model are:
• planning external or internal RTs with the subsequent, or even simultaneous, use of the TGF-α-deactivating drugs;
• preclinical testing new antitumour drugs that would substantially reduce the risk of extremely costly failures at the late phases of clinical trails;
• quantitative research of oncogenic hyperplasia in cancer and other proliferative diseases.
Future applications of the present model will allow to specify many still unclear features of oncogenic hyperplasia and help to discover ways to prevent the disease of at least fivethousand-year history. Derivations of equations from Section 4 A.1 Derivation of the reaction coefficient in (11) In order to obtain (11) from (5), one follows the derivation below The latter equality shows that m, η, and c are represented by (12) , (13) and (14), respectively.
A.2 Derivation of (19), and (20)
Substituting (8) into (14), one achieves
that, because of (15), results in (19) and (20) .
A.3 Derivation of (21)
Derivation of m + begins from (12) where value m is expressed by (18) . Thus,
Application of (14) The latter equality presents (21) .
A.4 Derivation of (22)
Relation (14) is equivalent to
where the numerator and the denominator can be substituted by (13) and (19) , respectively. This result in
that, in view of (6), leads to (22) .
A.5 Derivation of (24) Substituting (14) into (16), one obtains g as a function of c × , namely
In view of (8), (A.2) is transformed into
The latter equality is (24).
A.6 Derivation of (25) As it is noted in (16), 0 < g ≤ 1. Applying (24) to the latter relation, one obtains 0 < g × (1 + rη × ) − 3rη × ≤ 1 , which, after simple manipulations, is transformed into the form (25) . Relation (33) is used in (B.1) to obtain (30).
B.2 Derivation of (35)
It is possible to obtain relation for ν c from (30) and (38), i.e. that is equivalent to (39).
